GT Biopharma, Inc.
NASDAQShort interest in GT Biopharma has collapsed 54% over the past month while cost to borrow plunged 65%. Despite easing short pressure, shares fell 18% this week to $0.31. GTBP closed at $0.31 on April 24, down 13% on the day. The stock dropped 18% over the week and has lost 34% in the past month. The biotech trades in penny-stock territory with no…
GTBP short interest drops 20% over the past week to 5.1% of float, down from recent highs as cost to borrow eases to 10.5%.
Snapshot as of 9 May 2026
Short interest in GT Biopharma has collapsed 54% over the past month while cost to borrow plunged 65%. Despite easing short pressure, shares fell 18% this week to $0.31. GTBP closed at $0.31 on April 24, down 13% on…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for GTBP — free to start on ORTEX.
Sign up for free →Open GTBP on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live GTBP data →